Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Bone Miner Res ; 15(7): 1330-6, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10893681

ABSTRACT

The brittleness of bone in patients with osteogenesis imperfecta (OI) has been attributed to an aberrant collagen network. However, the role of collagen in the loss of tissue integrity has not been well established. To gain an insight into the biochemistry and structure of the collagen network, the cross-links hydroxylysylpyridinoline (HP) and lysylpyridinoline (LP) and the level of triple helical hydroxylysine (Hyl) were determined in bone of OI patients (types I, III, and IV) as well as controls. The amount of triple helical Hyl was increased in all patients. LP levels in OI were not significantly different; in contrast, the amount of HP (and as a consequence the HP/LP ratio and the total pyridinoline level) was significantly increased. There was no relationship between the sum of pyridinolines and the amount of triple helical Hyl, indicating that lysyl hydroxylation of the triple helix and the telopeptides are under separate control. Cross-linking is the result of a specific three-dimensional arrangement of collagens within the fibril; only molecules that are correctly aligned are able to form cross-links. Inasmuch as the total amount of pyridinoline cross-links in OI bone is similar to control bone, the packing geometry of intrafibrillar collagen molecules is not disturbed in OI. Consequently, the brittleness of bone is not caused by a disorganized intrafibrillar collagen packing and/or loss of cross-links. This is an unexpected finding, because mutant collagen molecules with a random distribution within the fibril are expected to result in disruptions of the alignment of neighboring collagen molecules. Pepsin digestion of OI bone revealed that collagen located at the surface of the fibril had lower cross-link levels compared with collagen located at the inside of the fibril, indicating that mutant molecules are not distributed randomly within the fibril but are located preferentially at the surface of the fibril.


Subject(s)
Bone and Bones/chemistry , Collagen/chemistry , Osteogenesis Imperfecta/metabolism , Pyridinium Compounds/analysis , Adolescent , Adult , Amino Acids/analysis , Arginine/analogs & derivatives , Arginine/analysis , Biomarkers/analysis , Biopsy , Bone and Bones/pathology , Child , Child, Preschool , Collagen/analysis , Collagen/metabolism , Humans , Hydroxylysine/analysis , Infant , Lysine/analogs & derivatives , Lysine/analysis , Osteogenesis Imperfecta/classification , Osteogenesis Imperfecta/pathology , Pepsin A , Reference Values
2.
Proc Natl Acad Sci U S A ; 96(3): 1054-8, 1999 Feb 02.
Article in English | MEDLINE | ID: mdl-9927692

ABSTRACT

Bruck syndrome is characterized by the presence of osteoporosis, joint contractures, fragile bones, and short stature. We report that lysine residues within the telopeptides of collagen type I in bone are underhydroxylated, leading to aberrant crosslinking, but that the lysine residues in the triple helix are normally modified. In contrast to bone, cartilage and ligament show unaltered telopeptide hydroxylation as evidenced by normal patterns of crosslinking. The results provide compelling evidence that collagen crosslinking is regulated primarily by tissue-specific enzymes that hydroxylate only telopeptide lysine residues and not those destined for the helical portion of the molecule. This new family of enzymes appears to provide the primary regulation for controlling the different pathways of collagen crosslinking and explains why crosslink patterns are tissue specific and not related to a genetic collagen type. A genome screen identified only a single region on chromosome 17p12 where all affected sibs shared a cluster of haplotypes identical by descent; this might be the BS (Bruck syndrome) locus and consequently the region where bone telopeptidyl lysyl hydroxylase is located. Further knowledge of this enzyme has important implications for conditions where aberrant expression of telopeptide lysyl hydroxylase occurs, such as fibrosis and scar formation.


Subject(s)
Bone Diseases/genetics , Bone and Bones/metabolism , Chromosomes, Human, Pair 17 , Collagen/metabolism , Contracture/genetics , Growth Disorders/genetics , Osteoporosis/genetics , Peptides/metabolism , Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase/genetics , Adolescent , Child , Child, Preschool , Chromosome Mapping , Collagen Type I , Consanguinity , Female , Genetic Markers , Genome, Human , Genotype , Homozygote , Humans , Ligaments/metabolism , Male , Pedigree , Syndrome
SELECTION OF CITATIONS
SEARCH DETAIL
...